![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.045.665 |
Chemical and physical data | |
Formula | C12H15N3O5S |
Molar mass | 313.33 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Amezinium metilsulfate (INN, trade name Regulton) is a sympathomimetic drug used for the treatment of low blood pressure. It has multiple mechanisms, including stimulation of alpha and beta-1 receptors and inhibition of noradrenaline and tyramine uptake. [1] [2]
This antidepressant is made from Chloridazon starting material.
The halogenation of 2-Butyne-1,4-diol [110-65-6] (1) with chlorine gives Mucochloric acid [87-56-9] (2). Treatment with Phenylhydrazine [100-63-0] (3) gives 1-Phenyl-4,5-dichloro-6-pyridazone [1698-53-9] (4). Addition of ammonia leads to Chloridazon [1698-60-8] (5). Catalytic hydrogenation yields 5-amino-2-phenylpyridazin-3-one [13589-77-0] (6). Alkylation with dimethyl sulfate completed the synthesis of Amezinium metisulfate (7).